Stockert 3T Heater-Cooler Lawsuits

Stockert 3T Heater-Cooler Lawsuits

Start Claim Now

The Stockert 3T heater-cooler system used to regulate body temperature during cardiopulmonary surgeries has been linked to nontuberculous mycobacteria (NTM) infections and other serious side effects.

Patients who undergo open-heart surgery and other cardiopulmonary operations where the Stockert 3T heater-cooler system is used, may be at risk for contamination by Mycobacterium chimaera, a bacteria that research shows may grow in the device’s water tanks and be released into the operating room through the heater-cooler’s exhaust vent. If you have been diagnosed with a nontuberculous mycobacteria (NTM) infection, and you believe the Stockert 3T system to be at fault, consult an experience product liability lawyer today to discuss your legal options. You may have grounds to file a product liability lawsuit against Stockert 3T maker LivaNova, in order to pursue the financial compensation you deserve for your injuries, medical expenses, pain and suffering, and other damages.

FDA, Stockert 3T and Side Effects

July 2015 – The FDA issues a recall of the Stockert 3T heater-cooler system, indicating that the medical device is associated with a “potential colonization of organisms, including Mycobacteria,” and instructing hospitals and other healthcare facilities that own Stockert 3T heater-cooler systems to maintain them with a new set of guidelines.

October 2015 – A safety communication issued by the FDA highlights the potential risk of mycobacteria infections from surgeries using heater-cooler devices like Stockert 3T, and indicates that between January 2010 and August 2015, the agency received 32 adverse event reports of “patient infections associated with heater-cooler devices or bacterial heater-cooler device contamination.”

October 2015 – The CDC issues a similar safety notice identifying “a need for increased vigilance for NTM infections” associated with heater-cooler devices used during cardiac surgical procedures.

November 2015 – Penn State Milton S. Hershey Medical Center notifies 2,300 patients about the potential for contaminated heater-cooler devices to spread bacteria.

December 2015 – The Pennsylvania Department of Health issues a warning regarding the risk of nontuberculous mycobacterium infections among patients undergoing open heart surgeries on cardiopulmonary bypass.

January 2016 – The FDA issues a warning letter to the Sorin Group, revealing safety violations uncovered during an inspection of the company’s production facilities in Germany and Colorado.

July 2016 – Another safety announcement issued by the FDA warns about Mycobacterium chimaera and the potential for the Stockert 3T to spread the bacteria during surgery, possibly causing “infections in very ill patients, including those with compromised immune systems, and chronic diseases or health conditions.”

October 2016 – The FDA issues an updated warning to patients and hospitals regarding recommendations on how to prevent the spread of infection.

Stockert 3T Side Effect Studies

May 2011 – A study of patients facing nontuberculous mycobacterial infections published in the European Respiratory Journal reports that the average treatment course was 14 months, and the average cost $4,916.

March 2015 – Researchers find six male patients between the ages of 49 and 64, with prosthetic valve endocarditis or vascular graft infections from M. chimaera bacteria. The bacteria is also found in heater-cooler units used during the patients’ open-chest heart surgeries.

July 2015 – The journal Clinical Infectious Diseases publishes research highlighting “Invasive Mycobacterium chimaera infections […] diagnosed in 2012 in 2 heart surgery patients on extracorporeal circulation.” The researchers warn in their conclusion about the “airborne transmission of M. chimaera from contaminated heater-cooler unit water tanks to patients during open-heart surgery.”

October 2015 – Ten patients with Mycobacterium chimaera infections are identified at three European hospitals, all of whom underwent open-heart surgery procedures using heater-cooler systems, according to a study published in the European Heart Journal.

October 2015 – An article published by the New York Times details the cases of at least eight patients who developed an infection from a heater-cooler device used during open-heart surgery at a hospital in York, Pennsylvania, four of whom died.

November 2015 – York Hospital in Pennsylvania notifies about 1,300 of its open-heart surgery patients that they could have been exposed to harmful bacteria during their procedure, between October 2011 and July 2015.

February 2016 – An article published by National Geographic highlights the “hidden epidemic of fatal infections linked to heart surgeries” allegedly caused by “spray from the fan of a heater-cooler device used to control the temperature of blood during a cardiac bypass, which contaminates both the otherwise-sterile operating field, and also any implants – a new valve, a vascular graft, being placed in or around the heart.”

February 2016 – Physicians working at the University of Iowa publicize one of their own patients who underwent cardiothoracic surgery at their hospital and subsequently developed an infection due to Mycobacterium chimaera.

June 2016 – Using smoke-dispersal techniques and video observation, researchers find that bacteria particles can travel from the ventilator of the heater-cooler system and enter the surgical area, where they can infect the patient.

Why We Think LivaNova Should Be Held Liable for Stockert 3T Infections

LivaNova currently manufactures 60% of all heater-cooler devices on the market, and lawsuits brought against LivaNova for Mycobacterium chimaera infections and other serious side effects accuse the medical device maker of:

  • Failure to warn about the potential risks of the Stockert 3T heater-cooler
  • Manufacturing a defective product
  • Negligence
  • Misrepresenting the risks of the Stockert 3T device

What should you do? If you have suffered a side effect like a Mycobacterium chimaera infection, you should contact a lawyer as soon as possible to discuss filing a Stockert 3T lawsuit.

More than 250,000 heart bypass procedures are performed by doctors every year, and more than 60% of these procedures use the Stockert 3T device, the most popular heater-cooler system for cardiac surgeries. Unfortunately, a growing body of research published in recent years shows that patients who undergo open-heart surgery and other operations where the Stockert 3T unit is used to regulate body temperature may be at risk for nontuberculous mycobacteria infections caused by exposure to Mycobacterium chimaera. If you believe you have been adversely affected by side effects of exposure to bacteria from a contaminated Stockert 3T heater-cooler device, contact a knowledgeable product liability lawyer today to explore your possible compensation options.

Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.